SEI Investments’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-116,506
Closed -$1.44M – 2867
2024
Q4
$1.44M Sell
116,506
-42,640
-27% -$488K ﹤0.01% 1795
2024
Q3
$1.81M Sell
159,146
-583
-0.4% -$5.85K ﹤0.01% 1726
2024
Q2
$1.14M Buy
159,729
+20,766
+15% +$159K ﹤0.01% 1864
2024
Q1
$931K Sell
138,963
-2,787
-2% -$19.2K ﹤0.01% 1913
2023
Q4
$921K Sell
141,750
-104,060
-42% -$671K ﹤0.01% 1901
2023
Q3
$2.32M Buy
245,810
+7,483
+3% +$90.1K ﹤0.01% 1539
2023
Q2
$3.33M Sell
238,327
-4,728
-2% -$80.6K 0.01% 1394
2023
Q1
$4.56M Buy
243,055
+11,061
+5% +$182K 0.01% 1232
2022
Q4
$3.19M Buy
231,994
+8,456
+4% +$130K 0.01% 1251
2022
Q3
$4.27M Sell
223,538
-7,077
-3% -$129K 0.01% 1164
2022
Q2
$3.46M Buy
230,615
+45,499
+25% +$673K 0.01% 1283
2022
Q1
$3.71M Buy
185,116
+31,817
+21% +$648K 0.01% 1263
2021
Q4
$4.47M Buy
153,299
+39,602
+35% +$1.13M 0.01% 1193
2021
Q3
$2.45M Buy
113,697
+17,136
+18% +$414K 0.01% 1428
2021
Q2
$2.48M Buy
96,561
+18,884
+24% +$403K 0.01% 1427
2021
Q1
$1.42M Hold
77,677
– – ﹤0.01% 1613
2020
Q4
$896K Buy
+77,677
New +$710K ﹤0.01% 1733
2018
Q3
– Sell
-928
Closed -$4K – 3517
2018
Q2
$4K Hold
928
– – ﹤0.01% 3227
2018
Q1
$3K Buy
928
+913
+6,087% +$2.82K ﹤0.01% 3197
2017
Q4
$0 Buy
+15
New +$64 ﹤0.01% 3526
2017
Q3
– Sell
-80
Closed – – 3424
2017
Q2
$0 Buy
+80
New +$327 ﹤0.01% 3321
2015
Q4
– Sell
-37,795
Closed -$270K – 2715
2015
Q3
$270K Buy
+37,795
New +$315K ﹤0.01% 1517

Other funds holding CDMO

SEI Investments's CDMO Position: Q1 2025 in Review

SEI Investments sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 116,506 shares — an estimated $1.44M sold.

SEI Investments first reported a position in CDMO in Q3 2015 and held it in 22 quarters. The position peaked at $4.56M in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • SEI Investments reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • SEI Investments sold 116,506 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $1.44M.
  • SEI Investments first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2015 and held it in 22 quarters.
  • SEI Investments's Avid Bioservices, Inc. Common Stock position peaked at $4.56M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on SEI Investments's 13F filing for Q1 2025, filed 13 May 2025.